New York gets $ 200 million in compensation in cause for opioids

Pharmaceutical company AbbVie resolved a lawsuit from New York claiming the drug manufacturer helped fuel the opioid crisis in the state. The company agreed to pay out 200 million dollars.

New York Attorney General Letitia James announced the settlement on Wednesday, the day in which the concluding arguments should have been heard in a proof it has stretched five months. Three-quarters of the settlement will be placed towards recovery programs for opiate addiction.

Read more

Spark of new opiates deadly wave of overdose in we

Spark of new opiates deadly wave of overdose in we

Pharmaceutical Teva remains a defendant in the lawsuit while the hearings proceed.

The cause is one of many in the United States against pharmaceutical companies, aimed at contacting their own role in skyrocketing opiate addiction in Country. James and attorneys from two New York counties tried to detain AbbVie and Teva responsible for the costs incurred by the government And public from opiate addiction.

AbbVie’s $ 200 million payment means Allergan, which is under its corporate umbrella, will be removed as defendant in the cause of opiates. James said the company has until mid-2022 to pay off the deal amount. Allergan also previously agreed to stop the sale of opioids.

Read More: World News

Source RT News.

Denial of any Responsibility!
AsumeTech is a News Source that Publishes News from its Editorial Team and the Automatic News Aggregation around the News Media. The Content is aggregated from RT News; each piece of Content includes the hyperlink to its Source. We have just rearranged that in our platform for Educational Purposes only. All the Copyrights and Trademarks belong to their Rightful Owners and all Materials to their Authors. If you do not want us to publish your materials on our Website, please get in touch with us by email – [email protected]; we will remove the Content from our Website.